• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TENX

TENX

Tenax Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD10.77

-0.18 (-1.64%)

Rating:C-

Company Profile

CEO

Christopher T. Giordano

IPO Date

1994-04-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.90

Prev. Close

$10.95

Day Low

$10.76

Day High

$11.34

52W Low

$5.34

52W High

$18.38

Market Cap

$0.19B

Volume

0.55M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

23.6%

Avg Negative

5.6%

Avg Neutral

71.0%

News Feed

TENX Stock Price Increases Over 12% Pre-Market: Why It Happened

Pulse2·6/23/2021·↑ positive

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX

Newsfile Corp·6/7/2021·↓ negative

Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update

Business Wire·5/17/2021·↑ positive

Tenax Therapeutics Stock Price Increased Over 35% Intraday: Why It Happened

Pulse2·4/9/2021·↑ positive

Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders

Business Wire·4/7/2021·↓ negative

Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update

Business Wire·3/31/2021·↑ positive

Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Business Wire·3/4/2021·↑ positive

Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med

Business Wire·1/20/2021·↑ positive

TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket

InvestorPlace·1/19/2021·↑ positive

Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med

Business Wire·1/19/2021·↑ positive